Portal de Periódicos da CAPES

Hypofractionated Versus Conventionally Fractionated Radiation Therapy for Prostate Cancer: Five-Year Oncologic Outcomes of the Dutch Randomized Phase 3 HYPRO Trial

2015; Elsevier BV; Volume: 94; Issue: 1 Linguagem: Inglês

10.1016/j.ijrobp.2015.10.045

1879-355X

Luca Incrocci, Ruud C. Wortel, Shafak Aluwini, Erik C. Schimmel, Augustinus D. G. Krol, P.P. van der Toorn, H. de Jager, M. Dirkx, Wendimagegn Alemayehu, B. Heijmen, Floris J. Pos,

Advanced Radiotherapy Techniques

Hypofractionated treatment might increase the radiobiological tumor dose without increasing toxicity due to the reported high radiation-fraction sensitivity of prostate cancer. Here, we present the first results on oncologic outcome from the Dutch randomized hypofractionation trial (HYPRO).